Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Filgrastim × 1 year × Clear all

Phase

Phase 2 41 Phase 1/2 15 Phase 1 12 Phase 3 11 Phase NA 2 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Magnetic Resonance Spectroscopy 20 pembrolizumab 13 Specimen Handling 13 Radiotherapy 13 Nivolumab 12 Cyclophosphamide 9 Fluorodeoxyglucose F18 8 Biopsy 8 X-Rays 7 fludarabine 6 Bevacizumab 6 venetoclax 5 Radiation 5 Metformin 5 Ipilimumab 5 Etoposide 5 Dexamethasone 5 olaparib 4 fluciclovine F-18 4 Temozolomide 4 Standard of Care 4 Rituximab 4 Paclitaxel 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Doxorubicin 4 Cisplatin 4 tislelizumab 3 gallium 68 PSMA-11 3 encorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01760226 2025-10-14

DA-EPOCH-R

Baylor College of Medicine

Phase EARLY_PHASE1 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡